Skip to main content
Top
Published in: Familial Cancer 1/2017

Open Access 01-01-2017 | Short Communication

Genetically diagnosed Birt–Hogg–Dubé syndrome and familial cerebral cavernous malformations in the same individual: a case report

Authors: James Whitworth, Brian Stausbøl-Grøn, Anne-Bine Skytte

Published in: Familial Cancer | Issue 1/2017

Login to get access

Abstract

When faced with an unusual clinical feature in a patient with a Mendelian disorder, the clinician may entertain the possibilities of either the feature representing a novel manifestation of that disorder or the co-existence of a different inherited condition. Here we describe an individual with a submandibular oncocytoma, pulmonary bullae and renal cysts as well as multiple cerebral cavernous malformations and haemangiomas. Genetic investigations revealed constitutional mutations in FLCN, associated with Birt–Hogg–Dubé syndrome (BHD) and CCM2, associated with familial cerebral cavernous malformation. Intracranial vascular pathologies (but not cerebral cavernous malformation) have recently been described in a number of individuals with BHD (Kapoor et al. in Fam Cancer 14:595–597, 10.​1007/​s10689-015-9807-y, 2015) but it is not yet clear whether they represent a genuine part of that conditions’ phenotypic spectrum. We suggest that in such instances of potentially novel clinical features, more extensive genetic testing to consider co-existing conditions should be considered where available. The increased use of next generation sequencing applications in diagnostic settings is likely to lead more cases such as this being revealed.
Literature
2.
go back to reference Toro JR (2008) Birt–Hogg–Dubé Syndrome. Gene Rev™ (internet) Toro JR (2008) Birt–Hogg–Dubé Syndrome. Gene Rev™ (internet)
5.
go back to reference Preston RS, Philp A, Claessens T, Gijezen L, Dydensborg AB, Dunlop EA, Harper KT, Brinkhuizen T, Menko FH, Davies DM, Land SC, Pause A, Baar K, van Steensel MAM, Tee AR (2011) Absence of the Birt–Hogg–Dubé gene product is associated with increased hypoxia-inducible factor transcriptional activity and a loss of metabolic flexibility. Oncogene 30:1159–1173. doi:10.1038/onc.2010.497 CrossRefPubMed Preston RS, Philp A, Claessens T, Gijezen L, Dydensborg AB, Dunlop EA, Harper KT, Brinkhuizen T, Menko FH, Davies DM, Land SC, Pause A, Baar K, van Steensel MAM, Tee AR (2011) Absence of the Birt–Hogg–Dubé gene product is associated with increased hypoxia-inducible factor transcriptional activity and a loss of metabolic flexibility. Oncogene 30:1159–1173. doi:10.​1038/​onc.​2010.​497 CrossRefPubMed
7.
go back to reference Morrison L, Akers A (2011) Cerebral Cavernous Malformation, Familial. Gene Rev™ (internet) Morrison L, Akers A (2011) Cerebral Cavernous Malformation, Familial. Gene Rev™ (internet)
Metadata
Title
Genetically diagnosed Birt–Hogg–Dubé syndrome and familial cerebral cavernous malformations in the same individual: a case report
Authors
James Whitworth
Brian Stausbøl-Grøn
Anne-Bine Skytte
Publication date
01-01-2017
Publisher
Springer Netherlands
Published in
Familial Cancer / Issue 1/2017
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-016-9928-y

Other articles of this Issue 1/2017

Familial Cancer 1/2017 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine